What is a stock summary page? Click here for an overview.
Business Description
Zim Laboratories Ltd
ISIN : INE518E01015
Share Class Description:
BOM:541400: Ordinary SharesCompare
Compare
Traded in other countries / regions
541400.India IPO Date
2018-06-08Description
Zim Laboratories Ltd is a pharmaceutical company. The company is mainly engaged in the manufacturing of formulation drugs and pre-formulation ingredients. Geographically, the group has a business presence in India and other countries, of which key revenue is derived from Outside India. The products offered by the company are Ondansetron, Melatonin, Nicotine, Vitamin D3, and others. The majority of its revenue is derived from the sale of pharmaceutical goods.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.42 | |||||
| Debt-to-EBITDA | 2.04 | |||||
| Interest Coverage | 2.82 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.64 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.8 | |||||
| 3-Year EBITDA Growth Rate | 8.5 | |||||
| 3-Year EPS without NRI Growth Rate | 16.3 | |||||
| 3-Year Book Growth Rate | 14.1 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.96 | |||||
| 9-Day RSI | 50.88 | |||||
| 14-Day RSI | 47.7 | |||||
| 3-1 Month Momentum % | -14.38 | |||||
| 6-1 Month Momentum % | -13.63 | |||||
| 12-1 Month Momentum % | -10.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | |||||
| Quick Ratio | 0.95 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 148.21 | |||||
| Days Sales Outstanding | 80.88 | |||||
| Days Payable | 111.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -10.69 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.03 | |||||
| Operating Margin % | 7.29 | |||||
| Net Margin % | 4.08 | |||||
| FCF Margin % | -15.32 | |||||
| ROE % | 6.52 | |||||
| ROA % | 3.72 | |||||
| ROIC % | 5.88 | |||||
| 3-Year ROIIC % | 1.66 | |||||
| ROC (Joel Greenblatt) % | 10.59 | |||||
| ROCE % | 10.76 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27 | |||||
| PE Ratio without NRI | 27 | |||||
| Shiller PE Ratio | 35.05 | |||||
| PEG Ratio | 3 | |||||
| PS Ratio | 1.11 | |||||
| PB Ratio | 1.71 | |||||
| Price-to-Tangible-Book | 1.93 | |||||
| Price-to-Operating-Cash-Flow | 25.46 | |||||
| EV-to-EBIT | 16.63 | |||||
| EV-to-EBITDA | 10.32 | |||||
| EV-to-Revenue | 1.35 | |||||
| EV-to-FCF | -8.83 | |||||
| Price-to-GF-Value | 0.79 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.99 | |||||
| Earnings Yield (Greenblatt) % | 6.01 | |||||
| FCF Yield % | -13.91 | |||||
| Forward Rate of Return (Yacktman) % | 13.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zim Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,762.489 | ||
| EPS (TTM) (₹) | 3.15 | ||
| Beta | 1.83 | ||
| 3-Year Sharpe Ratio | 0.35 | ||
| 3-Year Sortino Ratio | 0.69 | ||
| Volatility % | 40.59 | ||
| 14-Day RSI | 47.7 | ||
| 14-Day ATR (₹) | 4.556126 | ||
| 20-Day SMA (₹) | 83.872 | ||
| 12-1 Month Momentum % | -10.66 | ||
| 52-Week Range (₹) | 79.64 - 131.3 | ||
| Shares Outstanding (Mil) | 48.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zim Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zim Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zim Laboratories Ltd Frequently Asked Questions
What is Zim Laboratories Ltd(BOM:541400)'s stock price today?
The current price of BOM:541400 is ₹85.05. The 52 week high of BOM:541400 is ₹131.30 and 52 week low is ₹79.64.
When is next earnings date of Zim Laboratories Ltd(BOM:541400)?
The next earnings date of Zim Laboratories Ltd(BOM:541400) is .
Does Zim Laboratories Ltd(BOM:541400) pay dividends? If so, how much?
Zim Laboratories Ltd(BOM:541400) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers